… Acinetobacter baumannii is one such organism that turned … baumannii genome sequences
have broadened our understanding … baumannii pathogenesis. Bacterial factors known to be …

… Multidrug-resistant Acinetobacter baumannii is recognized to be among the most difficult …
to control and treat. Increasing antimicrobial resistance among Acinetobacter isolates has been …

Acinetobacter baumannii, once considered a low-category pathogen, has emerged as an
obstinate infectious agent. The scientific community is paying more attention to this pathogen …

… Acinetobacter baumannii (CRAB) is a perilous nosocomial pathogen causing substantial
morbidity and mortality. Current treatment options for … and other therapeutic options focusing on …

Bacteria within the genus Acinetobacter (principally A. baumannii-calcoaceticus complex [ABC])
are gram-negative coccobacilli that may cause nosocomial infections in critically ill or …

… a treatment option but are difficult to dose correctly and have significant side effects. Newer
treatment options … Combination therapy appears to be the best treatment option and should …

… as MDR, in which case, many treatment options are still available. In contrast, … baumannii.
Resistance to carbapenems poses a major challenge as the second-line treatment options …

… prospective treatment options for infections caused by multi-drug resistant A. baumannii
are … Prospective treatment options of Acinetobacter baumannii infections are summarized in …

… importance of Acinetobacter pittii and Acinetobacter nosocomialis has increased in the
nosocomial setting in the last decade, infections caused by Acinetobacter baumannii still have …

… Acinetobacter baumannii is an important cause of … current treatment of Acinetobacter
infections. Although controversy remains, the pooled data suggest that infections by A. baumannii …